These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25291583)

  • 21. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
    Starke JR;
    Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical signs of uveitis associated with latent tuberculosis.
    Ang M; Hedayatfar A; Zhang R; Chee SP
    Clin Exp Ophthalmol; 2012; 40(7):689-96. PubMed ID: 22299676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards better management of latent tuberculosis infection in children and young adults in the Maghreb. Conclusions of an expert meeting, Paris, 16 March 2018.
    Delacourt C; Zellweger JP;
    Arch Pediatr; 2019 Feb; 26(2):126-129. PubMed ID: 30642745
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study.
    Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent tuberculosis in children: diagnosis and management.
    Singh M; Saini AG; Anil N; Aggarwal A
    Indian J Pediatr; 2011 Apr; 78(4):464-8. PubMed ID: 21128015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scaling up of latent tuberculosis infection treatment for close contacts of tuberculosis in Taiwan.
    Chan PC; Yang CH; Chang FY
    J Formos Med Assoc; 2011 Dec; 110(12):733-6. PubMed ID: 22351971
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It is time to deal with latent tuberculosis infection in Taiwan.
    Chan PC; Huang LM; Suo J
    J Formos Med Assoc; 2009 Dec; 108(12):901-3. PubMed ID: 20040453
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis.
    Ruan Q; Zhang S; Ai J; Shao L; Zhang W
    Clin Rheumatol; 2016 Feb; 35(2):417-25. PubMed ID: 25376466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.
    Esmail H; Barry CE; Wilkinson RJ
    Drug Discov Today; 2012 May; 17(9-10):514-21. PubMed ID: 22198298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon gamma release assays based on M. tuberculosis-specific antigens in sarcoidosis patients.
    Kempisty A; Białas-Chromiec B; Borkowska D; Kuś J
    Pneumonol Alergol Pol; 2015; 83(2):126-34. PubMed ID: 25754054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QuantiFERON-TB Gold In-Tube test performance in a large pediatric population investigated for suspected tuberculosis infection.
    Chiappini E; Storelli F; Tersigni C; Venturini E; de Martino M; Galli L
    Paediatr Respir Rev; 2019 Nov; 32():36-47. PubMed ID: 31155511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Latent tuberculosis].
    Bonomo C; Brändli O; Rampini SK
    Praxis (Bern 1994); 2011 Feb; 100(3):125-36. PubMed ID: 21290367
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis.
    Agarwal SK; Singh UB; Zaidi SH; Gupta S; Pandey RM
    Indian J Med Res; 2015 Apr; 141(4):463-8. PubMed ID: 26112848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of latent tuberculosis.
    Turetz ML; Ma KC
    Curr Opin Infect Dis; 2016 Apr; 29(2):205-11. PubMed ID: 26836374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.